The function of miR-200 family in oxidative stress response evoked in cancer chemotherapy and radiotherapy.

Joanna Kozak, Katarzyna Jonak, Ryszard Maciejewski

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2020 May

filter terms:

Since the beginning of the discovery of microRNAs (miRs), these molecules have attracted highly progressive attention due to their powerful regulatory roles in a broad spectrum of biological processes, including proliferation, differentiation, apoptosis and carcinogenesis. With regard to carcinogenesis, the miRs regulatory potency has been associated with cancer onset, progression, metastasis, diagnosis and therapeutic response. In this review we discuss the impact of miR-200 family on drug resistance development during anti-cancer therapy. Developing resistance to chemotherapeutic drugs as well as radiotherapy are major clinical obstacles in the successful therapeutic strategies to cancer treatment. Acquired cancer chemoresistance is a multifactorial phenomenon involving such factors as tumor type, tumor stage, cellular reactive oxygen species (ROS) level or ROS-responsive miRs profile. ROS level could influence the miRs expression level, which changes the cellular profile of the content of miRs. Such significant changes in the cellular miRs profile generate subsequent biological effects through the regulation of their target genes. This review outlines the interactions between ROS and miR-200 family in different kinds of cancers in response to chemotherapy. Copyright © 2020 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Citation

Joanna Kozak, Katarzyna Jonak, Ryszard Maciejewski. The function of miR-200 family in oxidative stress response evoked in cancer chemotherapy and radiotherapy. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2020 May;125:110037